Cargando…

Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner

The D40 gene encodes a kinetochore protein that plays an essential role in kinetochore formation during mitosis. Short inhibitory RNA against D40, D40 siRNA, has been shown to deplete the D40 protein in the human cancer cell line HeLa, which harbors wild-type p53, and this activity was followed by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Urata, Yuri N., Takeshita, Fumitaka, Tanaka, Hiroki, Ochiya, Takahiro, Takimoto, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562263/
https://www.ncbi.nlm.nih.gov/pubmed/26348410
http://dx.doi.org/10.1038/srep13676
_version_ 1782389146299400192
author Urata, Yuri N.
Takeshita, Fumitaka
Tanaka, Hiroki
Ochiya, Takahiro
Takimoto, Masato
author_facet Urata, Yuri N.
Takeshita, Fumitaka
Tanaka, Hiroki
Ochiya, Takahiro
Takimoto, Masato
author_sort Urata, Yuri N.
collection PubMed
description The D40 gene encodes a kinetochore protein that plays an essential role in kinetochore formation during mitosis. Short inhibitory RNA against D40, D40 siRNA, has been shown to deplete the D40 protein in the human cancer cell line HeLa, which harbors wild-type p53, and this activity was followed by the significant inhibition of cell growth and induction of apoptotic cell death. The p53-null cancer cell line, PC-3M-luc, is also sensitive to the significant growth inhibition and cell death induced by D40 siRNA. The growth of PC-3M-luc tumors transplanted into nude mice was inhibited by the systemic administration of D40 siRNA and the atelocollagen complex. Furthermore, D40 siRNA significantly inhibited growth and induced apoptotic cell death in a cell line with a gain-of-function (GOF) mutation in p53, MDA-MB231-luc, and also inhibited the growth of tumors transplanted into mice when administered as a D40 siRNA/atelocollagen complex. These results indicated that D40 siRNA induced apoptotic cell death in human cancer cell lines, and inhibited their growth in vitro and in vivo regardless of p53 status. Therefore, D40 siRNA is a potential candidate anti-cancer reagent.
format Online
Article
Text
id pubmed-4562263
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-45622632015-09-15 Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner Urata, Yuri N. Takeshita, Fumitaka Tanaka, Hiroki Ochiya, Takahiro Takimoto, Masato Sci Rep Article The D40 gene encodes a kinetochore protein that plays an essential role in kinetochore formation during mitosis. Short inhibitory RNA against D40, D40 siRNA, has been shown to deplete the D40 protein in the human cancer cell line HeLa, which harbors wild-type p53, and this activity was followed by the significant inhibition of cell growth and induction of apoptotic cell death. The p53-null cancer cell line, PC-3M-luc, is also sensitive to the significant growth inhibition and cell death induced by D40 siRNA. The growth of PC-3M-luc tumors transplanted into nude mice was inhibited by the systemic administration of D40 siRNA and the atelocollagen complex. Furthermore, D40 siRNA significantly inhibited growth and induced apoptotic cell death in a cell line with a gain-of-function (GOF) mutation in p53, MDA-MB231-luc, and also inhibited the growth of tumors transplanted into mice when administered as a D40 siRNA/atelocollagen complex. These results indicated that D40 siRNA induced apoptotic cell death in human cancer cell lines, and inhibited their growth in vitro and in vivo regardless of p53 status. Therefore, D40 siRNA is a potential candidate anti-cancer reagent. Nature Publishing Group 2015-09-08 /pmc/articles/PMC4562263/ /pubmed/26348410 http://dx.doi.org/10.1038/srep13676 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Urata, Yuri N.
Takeshita, Fumitaka
Tanaka, Hiroki
Ochiya, Takahiro
Takimoto, Masato
Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner
title Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner
title_full Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner
title_fullStr Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner
title_full_unstemmed Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner
title_short Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner
title_sort targeted knockdown of the kinetochore protein d40/knl-1 inhibits human cancer in a p53 status-independent manner
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562263/
https://www.ncbi.nlm.nih.gov/pubmed/26348410
http://dx.doi.org/10.1038/srep13676
work_keys_str_mv AT uratayurin targetedknockdownofthekinetochoreproteind40knl1inhibitshumancancerinap53statusindependentmanner
AT takeshitafumitaka targetedknockdownofthekinetochoreproteind40knl1inhibitshumancancerinap53statusindependentmanner
AT tanakahiroki targetedknockdownofthekinetochoreproteind40knl1inhibitshumancancerinap53statusindependentmanner
AT ochiyatakahiro targetedknockdownofthekinetochoreproteind40knl1inhibitshumancancerinap53statusindependentmanner
AT takimotomasato targetedknockdownofthekinetochoreproteind40knl1inhibitshumancancerinap53statusindependentmanner